Cox Troy
SEC insider (Form 3/4/5 filer). CIK 0001696923. Director at MapLight Therapeutics, Inc. (MPLT) and 3 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in REDWOOD CITY, CA.
Companies Cox Troy has filed insider reports for
- MapLight Therapeutics, Inc. (MPLT): Director
- STANDARD BIOTOOLS INC. (LAB): Director
- SOPHiA GENETICS SA (SOPH): Director
- Zymeworks Inc. (ZYME): Director
Cox Troy
CIK: 0001696923
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jul 28, 2026MPLT
MapLight Therapeutics, Inc.
PurchaseIndirect15.6K shares at avg. $9.52$149K - Jun 23, 2026MPLT
MapLight Therapeutics, Inc.
AwardDirect7.9K shares- - Jun 18, 2026LAB
STANDARD BIOTOOLS INC.
AwardDirect99.1K shares- - Jun 18, 2026SOPH
SOPHiA GENETICS SA
AwardDirect19.7K shares at avg. $5.46$108K - Feb 26, 2026LAB
STANDARD BIOTOOLS INC.
AwardDirect57.3K shares at avg. $1.17$67K - Jun 20, 2025LAB
STANDARD BIOTOOLS INC.
AwardDirect94.6K shares- - Feb 28, 2025LAB
STANDARD BIOTOOLS INC.
AwardDirect62.9K shares at avg. $1.06$67K - Dec 10, 2024ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
31K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 |  MPLT MapLight Therapeutics, Inc. | Purchase | 15,620 | $9.52 | $148,702 | Indirect |
| Jun 23, 2026 | MPLT MapLight Therapeutics, Inc. | Award | 7,864 | - | $0 | Direct |
| Jun 18, 2026 |  LAB STANDARD BIOTOOLS INC. | Award | 99,116 | - | $0 | Direct |
| Jun 18, 2026 |  SOPH SOPHiA GENETICS SA | Award | 19,724 | $5.46 | $107,693 | Direct |
| Feb 26, 2026 | LAB STANDARD BIOTOOLS INC. | Award | 57,264 | $1.17 | $66,999 | Direct |
| Jun 20, 2025 | LAB STANDARD BIOTOOLS INC. | Award | 94,592 | - | - | Direct |
| Feb 28, 2025 | LAB STANDARD BIOTOOLS INC. | Award | 62,910 | $1.06 | $66,999 | Direct |
| Dec 10, 2024 |  ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 31,000 | - | - | Direct |
1-8 of 8 transactions